Tandem Diabetes Care Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) Transcript
Hello, everyone. Welcome back to the Oppenheimer Life Sciences and MedTech Summit. My name is Steve Lichtman, Senior Medical Devices analyst here at Oppenheimer. Very happy to have with us up next Tandem Diabetes Care. With us today is John Sheridan, President and CEO; Susan Morrison, EVP and CAO; and Ms. Gasser, EVP, Strategy and Corporate Development.
I'm going to turn the podium briefly over to John, who's going to have a couple of remarks to kick us off. And then we're going to do a fireside chat format, which I'll lead the Q&A. And if you have any questions, please submit them through the link that was sent to you, and I'll get them right over to management.
And with that, I'm going to turn it over to John.
Thanks, Steve. It's really nice to be here today. I'd just like to start off by reminding people of where we came from. And that is that Tandem from the very
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |